FDA Inspection 1101800 — DAP Pharmaceuticals, LLC
The FDA completed an inspection of DAP Pharmaceuticals, LLC on September 11, 2019 in Lake Park, FL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- September 11, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Lake Park, FL (United States)